Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse. - Wikidata - wikimedia - TriplyDB

Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse.

Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse.

http://www.wikidata.org/entity/Q37162532

about

Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.Fibrosis: a key feature of Fabry disease with potential therapeutic implications Neointimal hyperplasia and vasoreactivity are controlled by genetic elements on rat chromosome 3.Fabry's disease: an example of cardiorenal syndrome type 5.A Comparison of Genetic Diversity of COX-III Gene in Lowland Chickens and Tibetan Chickens.Xanthine oxidase inhibition protects against Western diet-induced aortic stiffness and impaired vasorelaxation in female mice.Pathomechanisms of renal Fabry disease.Fabry disease

P2860

Q26745698-0A6DE09A-2CD8-462C-B098-C5AE7CC61493 Q34257466-15E01793-DE16-4630-8C08-8F451F9C4171 Q37113004-F12CC459-4FD6-4E4F-B70E-7E7214744B5C Q37151730-32B9A06F-FE7F-4E08-8EBD-C7300FA307C1 Q38558725-0F42CD72-434C-4892-A45C-2B7760EFF0DB Q41026127-DCCD6529-6A19-402D-9FD5-7F468814D5F5 Q47754216-D6910586-E6DF-4CAF-9EB8-C8AB69CF15F9 Q48287690-BE6F6A2D-F716-47CF-9E4C-0352888B1F14 Q56905945-488B3193-7F61-400A-AE4F-02336264753D

P2860

Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse.

http://www.wikidata.org/entity/Q37162532

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Differential involvement of CO ...... alactosidase A-knockout mouse.

@en

Differential involvement of CO ...... alactosidase A-knockout mouse.

@nl

type

label

Differential involvement of CO ...... alactosidase A-knockout mouse.

@en

Differential involvement of CO ...... alactosidase A-knockout mouse.

@nl

prefLabel

Differential involvement of CO ...... alactosidase A-knockout mouse.

@en

Differential involvement of CO ...... alactosidase A-knockout mouse.

@nl

P1433

Q37162532-31B01628-FA9A-4413-8D1C-D6ED6AD91099

P1476

Q37162532-B97ED0F8-D5A4-44B4-ACA1-4A5696BCA475

P2093

Q37162532-53C0FD7C-969C-4ECB-A7EC-8B0FFF3C5A1E

Q37162532-F5156191-0165-45BD-997E-5A0B95EF1C98

Q37162532-FEC08557-8940-4430-967A-7D1BCAEECF27

P2860

Q37162532-04209461-09FE-410F-B0ED-97580B24BAD5

Q37162532-11086088-F489-4543-8F4F-C3668735FBB3

Q37162532-1332E177-DF42-4E22-922F-ACCD37630395

Q37162532-1E0BA168-53BF-4A8E-B8AE-81BB77916F3E

Q37162532-27ACD40F-9BA6-4A67-BD27-5925C84F6142

Q37162532-2C6D02CC-3F9D-45B4-B9BC-749494E8E39D

Q37162532-32B67744-13CA-4074-B3C4-148132E001C2

Q37162532-32E83F11-5D37-4760-B7D3-DEE76D1DF980

Q37162532-4B34CB2B-448D-4522-858E-DE37502BB713

Q37162532-4D7D3919-2202-49CF-826C-C042BA946746

P304

Q37162532-26647953-2E54-4CC0-880E-087C5CCA383C

P31

Q37162532-99D6FCA1-45A2-4D29-BB76-1D9CF77112EE

P356

Q37162532-F5D0940E-5E0C-4B9F-ACAE-63F73A8752E0

P433

Q37162532-D4E2B135-14A9-45D3-B868-858624FCE4AF

P478

Q37162532-CC5868A8-C7C2-4A8E-B42B-2A621D8770A3

P577

Q37162532-D27F3672-F44E-4FCC-B7DA-B950FCDC3486

P5875

Q37162532-0978B058-E290-4842-A887-9A1C443F783F

P698

Q37162532-9FFAEA59-3979-4C3D-ABD1-D6DCC1C4240E

P921

Q37162532-E8CC3D95-93B7-4AE1-992B-6125A7C4496E

P932

Q37162532-3146DC32-1497-405C-8B0C-B562E23F74E9

P356

AJPHEART.00929.2008

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Differential involvement of CO ...... alactosidase A-knockout mouse.

@en

P2093

James A Shayman

http://www.w3.org/2001/XMLSchema#string

James L Park

http://www.w3.org/2001/XMLSchema#string

Liming Shu

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

Enhanced endothelium-dependent vasodilation in Fabry disease

alpha-Galactosidase A deficient mice: a model of Fabry disease

Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing.

Endothelium-dependent contractions in hypertension.

Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A

COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice.

P304

H1133-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00929.2008

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

296

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23989445

http://www.w3.org/2001/XMLSchema#string

P698

19202000

http://www.w3.org/2001/XMLSchema#string

P921

P932

2670691

http://www.w3.org/2001/XMLSchema#string